acetazolamide has been researched along with Chronic Disease in 96 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this study was to determine the diuretic effect of acetazolamide in patients with exacerbations of chronic heart failure, in addition to their stable diuretic therapy." | 9.24 | Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study. ( Budaj, A; Imiela, T, 2017) |
"To study the effect of acetazolamide on cystoid macular edema in patients with uveitis." | 9.08 | A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. ( Chew, EY; Csaky, KG; Nussenblatt, RB; Perry, CH; Podgor, MJ; Whitcup, SM, 1996) |
", West Point, PA), a carbonic anhydrase inhibitor, with that of oral acetazolamide (Diamox; Lederle Laboratories, Pearl River, NY) for the management of chronic cystoid macular edema in patients with retinitis pigmentosa." | 9.08 | Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. ( Adelman, AE; Fiscella, RG; Fishman, GA; Grover, S, 1997) |
"Thirty patients with cystoid macular oedema secondary to chronic iridocyclitis were enrolled in a two period, prospective, randomised, double masked, crossover study that compared sustained release acetazolamide (500 mg twice a day) with a placebo to measure the effects on the reduction of cystoid macular oedema and improvement of visual acuity." | 9.07 | Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. ( Cross, A; Farber, MD; Jennings, TJ; Lam, S; Rusin, MM; Tessler, HH, 1994) |
"We tested the effect of acetazolamide on blood mechanical properties and pulmonary vascular resistance (PVR) during chronic hypoxia." | 7.78 | Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics. ( Brunet, J; Connes, P; Cymbalista, F; Favret, F; Levy, BI; Maignan, M; Marchant, D; Pichon, A; Quidu, P; Richalet, JP; Safeukui, I; Vilar, J, 2012) |
"Cerebral blood flow (CBF) and response to acetazolamide were measured during the acute, subacute, and chronic stages after aneurysmal subarachnoid hemorrhage and correlated with symptomatic vasospasm and clinical outcome in 45 patients who underwent early clipping of ruptured cerebral aneurysms, of whom 18 had symptomatic vasospasm and 27 did not." | 7.70 | Cerebral blood flow and the response to acetazolamide during the acute, subacute, and chronic stages of aneurysmal subarachnoid hemorrhage. ( Nakayama, Y; Tanaka, A; Tomonaga, M; Yoshinaga, S, 1998) |
"The aim of this study was to compare the effect of vasodilative stimuli for the measurement of cerebrovascular reactivity obtained by acetazolamide and hypercapnia in patients with chronic occlusive major cerebral artery disease." | 7.69 | Dissociation of vasoreactivity to acetazolamide and hypercapnia. Comparative study in patients with chronic occlusive major cerebral artery disease. ( Houkin, K; Ishikawa, T; Kazumata, K; Kuroda, S; Mitsumori, K; Tanaka, N, 1996) |
"To evaluate the efficacy of 133Xe SPECT and Diamox test, for selecting patients with hemodynamic compromise, tests using 133Xe inhalation method and single photon emission computed tomography (SPECT) with acetazolamide (Diamox) were performed in twenty-three patients with chronic cerebral ischemia, before and after extracranial-intracranial bypass surgery or carotid-endarterectomy." | 7.68 | [Diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; the detection of impaired vasodilatory capacity with 133Xe SPECT and acetazolamide (Diamox) test]. ( Abe, H; Kamiyama, H; Kuroda, S; Mitsumori, K; Motomiya, M; Nakagawa, T; Sakuragi, M; Takigawa, S; Tsuru, M, 1990) |
"In a prospective study, 41 patients with documented chronic macular edema of various causes were entered into a therapeutic trial of acetazolamide sodium, a carbonic anhydrase inhibitor." | 7.67 | Treatment of chronic macular edema with acetazolamide. ( Bird, AC; Cox, SN; Hay, E, 1988) |
"CVR is impaired in alert patients with cerebral infarction, although the mean CBF is not reduced, and good collateral flow via the anterior communicating artery in patients with carotid occlusion may be a sign of well-preserved haemodynamic status." | 6.70 | Cerebrovascular reactivity to acetazolamide in alert patients with cerebral infarction: usefulness of first-pass radionuclide angiography using 99m Tc-HMPAO in monitoring cerebral haemodynamics. ( Chang, CC; Kanno, H; Kuwana, N; Yamamoto, I, 2001) |
"Acetazolamide treatment did not significantly affect the expression of vascular endothelial growth factor in the tissues studied." | 5.36 | Aquaporin-1 expression and angiogenesis in rabbit chronic myocardial ischemia is decreased by acetazolamide. ( Chen, Y; Liang, Y; Liu, W; Lv, X; Ran, X; Sun, J; Wang, B; Wang, H; Zeng, Z; Zhang, K; Zheng, R; Zhou, Q, 2010) |
"The aim of this study was to determine the diuretic effect of acetazolamide in patients with exacerbations of chronic heart failure, in addition to their stable diuretic therapy." | 5.24 | Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study. ( Budaj, A; Imiela, T, 2017) |
"Although the effects of acetazolamide (ACZ) on ventilation during acute mountain sickness are well known, there are no studies assessing its effect on ventilatory response in chronic hypoxia." | 5.13 | Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness. ( Bouchet, P; Huicho, L; León-Velarde, F; Richalet, JP; Rivera-Ch, M, 2008) |
"To study the effect of acetazolamide on cystoid macular edema in patients with uveitis." | 5.08 | A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. ( Chew, EY; Csaky, KG; Nussenblatt, RB; Perry, CH; Podgor, MJ; Whitcup, SM, 1996) |
", West Point, PA), a carbonic anhydrase inhibitor, with that of oral acetazolamide (Diamox; Lederle Laboratories, Pearl River, NY) for the management of chronic cystoid macular edema in patients with retinitis pigmentosa." | 5.08 | Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. ( Adelman, AE; Fiscella, RG; Fishman, GA; Grover, S, 1997) |
"Thirty patients with cystoid macular oedema secondary to chronic iridocyclitis were enrolled in a two period, prospective, randomised, double masked, crossover study that compared sustained release acetazolamide (500 mg twice a day) with a placebo to measure the effects on the reduction of cystoid macular oedema and improvement of visual acuity." | 5.07 | Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. ( Cross, A; Farber, MD; Jennings, TJ; Lam, S; Rusin, MM; Tessler, HH, 1994) |
"We tested the effect of acetazolamide on blood mechanical properties and pulmonary vascular resistance (PVR) during chronic hypoxia." | 3.78 | Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics. ( Brunet, J; Connes, P; Cymbalista, F; Favret, F; Levy, BI; Maignan, M; Marchant, D; Pichon, A; Quidu, P; Richalet, JP; Safeukui, I; Vilar, J, 2012) |
"Three normal volunteers and 12 patients with an obstruction of major cerebral arteries underwent PET measurements of the CBF after an injection of H2(15)O: (1) in the resting condition, (2) during hyperventilation (HV scan), (3) 1 to 3 minutes after hyperventilation (post-HV scan), (4) during the inhalation of 5% CO2, and (5) after an injection of acetazolamide." | 3.70 | Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study. ( Hirakawa, K; Ishii, K; Matsushima, Y; Nariai, T; Senda, M; Toyama, H; Wakabayashi, S; Yokota, T, 1998) |
"Cerebral blood flow (CBF) and response to acetazolamide were measured during the acute, subacute, and chronic stages after aneurysmal subarachnoid hemorrhage and correlated with symptomatic vasospasm and clinical outcome in 45 patients who underwent early clipping of ruptured cerebral aneurysms, of whom 18 had symptomatic vasospasm and 27 did not." | 3.70 | Cerebral blood flow and the response to acetazolamide during the acute, subacute, and chronic stages of aneurysmal subarachnoid hemorrhage. ( Nakayama, Y; Tanaka, A; Tomonaga, M; Yoshinaga, S, 1998) |
"The aim of this study was to compare the effect of vasodilative stimuli for the measurement of cerebrovascular reactivity obtained by acetazolamide and hypercapnia in patients with chronic occlusive major cerebral artery disease." | 3.69 | Dissociation of vasoreactivity to acetazolamide and hypercapnia. Comparative study in patients with chronic occlusive major cerebral artery disease. ( Houkin, K; Ishikawa, T; Kazumata, K; Kuroda, S; Mitsumori, K; Tanaka, N, 1996) |
"To assess the responsiveness of the cerebral vessels to chronic hypercapnia, we measured middle cerebral artery flow velocity by transcranial Doppler ultrasound in 20 normal subjects and in 14 COLD patients before and after stimulation by progressive hypercapnia (rebreathing test) or by intravenous administration of an acetazolamide bolus." | 3.68 | Cerebral vascular responsiveness in chronic hypercapnia. ( Cavestri, R; Ciofetti, M; Clivati, A; Longhini, E, 1992) |
"To evaluate the efficacy of 133Xe SPECT and Diamox test, for selecting patients with hemodynamic compromise, tests using 133Xe inhalation method and single photon emission computed tomography (SPECT) with acetazolamide (Diamox) were performed in twenty-three patients with chronic cerebral ischemia, before and after extracranial-intracranial bypass surgery or carotid-endarterectomy." | 3.68 | [Diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; the detection of impaired vasodilatory capacity with 133Xe SPECT and acetazolamide (Diamox) test]. ( Abe, H; Kamiyama, H; Kuroda, S; Mitsumori, K; Motomiya, M; Nakagawa, T; Sakuragi, M; Takigawa, S; Tsuru, M, 1990) |
"In a prospective study, 41 patients with documented chronic macular edema of various causes were entered into a therapeutic trial of acetazolamide sodium, a carbonic anhydrase inhibitor." | 3.67 | Treatment of chronic macular edema with acetazolamide. ( Bird, AC; Cox, SN; Hay, E, 1988) |
"Multiple serum chemical values were examined in 92 patients with chronic glaucoma who were treated with the carbonic anhydrase inhibitors (CAIs) acetazolamide or methazolamide, seeking relationships between serum composition and symptomatic side effects." | 3.65 | Carbonic anhydrase inhibitor side effects. Serum chemical analysis. ( Epstein, DL; Grant, WM, 1977) |
"Fifteen patients with carotid artery stenosis ≥ 90% on the ipsilateral side and <50% on the contralateral side were enrolled into the study." | 2.78 | Near-infrared transillumination back scattering sounding--new method to assess brain microcirculation in patients with chronic carotid artery stenosis. ( Bandurski, T; Frydrychowski, AF; Halena, G; Szarmach, A; Winklewski, PJ, 2013) |
"CVR is impaired in alert patients with cerebral infarction, although the mean CBF is not reduced, and good collateral flow via the anterior communicating artery in patients with carotid occlusion may be a sign of well-preserved haemodynamic status." | 2.70 | Cerebrovascular reactivity to acetazolamide in alert patients with cerebral infarction: usefulness of first-pass radionuclide angiography using 99m Tc-HMPAO in monitoring cerebral haemodynamics. ( Chang, CC; Kanno, H; Kuwana, N; Yamamoto, I, 2001) |
"Murine typhus is a systemic febrile illness caused by Rickettsia typhi, a gram-negative, obligate intracellular bacterium." | 2.50 | Murine typhus as a cause of cognitive impairment: case report and a review of the literature. ( Bergamo, DF; Carr, SB; Emmanuel, PJ; Ferreira, JA, 2014) |
"Acetazolamide treatment did not significantly affect the expression of vascular endothelial growth factor in the tissues studied." | 1.36 | Aquaporin-1 expression and angiogenesis in rabbit chronic myocardial ischemia is decreased by acetazolamide. ( Chen, Y; Liang, Y; Liu, W; Lv, X; Ran, X; Sun, J; Wang, B; Wang, H; Zeng, Z; Zhang, K; Zheng, R; Zhou, Q, 2010) |
"Normocapnic and chronic hypercapnic COPD patients have the same ventilatory and cerebrovascular carbon dioxide responsiveness irrespective of induced metabolic state." | 1.31 | Effects of acetazolamide and furosemide on ventilation and cerebral blood volume in normocapnic and hypercapnic patients with COPD. ( Colier, WN; Folgering, H; Oeseburg, B; van de Ven, MJ; van der Sluijs, MC; Vis, P, 2002) |
"We report two cases of idiopathic intracranial hypertension causing chronic daily headache with migrainous features in the absence of associated papilledema." | 1.29 | Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension. ( Huff, AL; Hupp, SL; Rothrock, JF, 1996) |
"Patients with mixed chronic respiratory acidosis and metabolic alkalosis constitute a common subgroup of patients with chronic obstructive lung disease and carbon dioxide retention; these patients benefit from correction of the metabolic alkalosis." | 1.26 | Effect of metabolic alkalosis on respiratory function in patients with chronic obstructive lung disease. ( Bear, R; Feldman, R; Goldstein, M; Halperin, M; Hammeke, M; Handelsman, S; Ho, M; Phillipson, E, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (41.67) | 18.7374 |
1990's | 29 (30.21) | 18.2507 |
2000's | 14 (14.58) | 29.6817 |
2010's | 11 (11.46) | 24.3611 |
2020's | 2 (2.08) | 2.80 |
Authors | Studies |
---|---|
Yang, HL | 1 |
Deng, MJ | 1 |
Zhang, W | 1 |
Huang, S | 1 |
Luks, AM | 1 |
Hackett, PH | 1 |
Imiela, T | 1 |
Budaj, A | 1 |
Szarmach, A | 2 |
Kaszubowski, M | 1 |
Sabisz, A | 1 |
Frydrychowski, AF | 2 |
Halena, G | 2 |
Piskunowicz, M | 1 |
Dzierzanowski, J | 1 |
Studniarek, M | 1 |
Szurowska, E | 1 |
Winklewski, PJ | 2 |
Shah, P | 1 |
Liu, X | 1 |
Hodgetts, T | 1 |
Sii, F | 1 |
Bandurski, T | 1 |
Carr, SB | 1 |
Bergamo, DF | 1 |
Emmanuel, PJ | 1 |
Ferreira, JA | 1 |
Tugcu, B | 1 |
Nacaroglu, SA | 1 |
Coskun, C | 1 |
Kuscu, DY | 1 |
Onder, F | 1 |
Ranieri, A | 1 |
Topa, A | 1 |
Cavaliere, M | 1 |
De Simone, R | 1 |
Yu, H | 1 |
Qi, GL | 1 |
Wang, J | 1 |
Chen, L | 1 |
Deng, Z | 1 |
Zhao, YS | 1 |
Lei, SS | 1 |
Zhu, XQ | 1 |
Rivera-Ch, M | 3 |
Huicho, L | 2 |
Bouchet, P | 2 |
Richalet, JP | 4 |
León-Velarde, F | 4 |
Inoue, N | 1 |
Harada, M | 1 |
Gandhi, MS | 1 |
Deshmukh, PA | 1 |
Kamalov, G | 1 |
Zhao, T | 1 |
Zhao, W | 1 |
Whaley, JT | 1 |
Tichy, JR | 1 |
Bhattacharya, SK | 1 |
Ahokas, RA | 1 |
Sun, Y | 1 |
Gerling, IC | 1 |
Weber, KT | 1 |
Ran, X | 1 |
Wang, H | 1 |
Chen, Y | 1 |
Zeng, Z | 1 |
Zhou, Q | 1 |
Zheng, R | 1 |
Sun, J | 1 |
Wang, B | 1 |
Lv, X | 1 |
Liang, Y | 1 |
Zhang, K | 1 |
Liu, W | 1 |
Pichon, A | 1 |
Connes, P | 1 |
Quidu, P | 1 |
Marchant, D | 1 |
Brunet, J | 1 |
Levy, BI | 1 |
Vilar, J | 1 |
Safeukui, I | 1 |
Cymbalista, F | 1 |
Maignan, M | 2 |
Favret, F | 1 |
Sood, V | 1 |
Rejali, D | 1 |
Stocker, J | 1 |
Pagliarini, S | 1 |
Ahluwalia, H | 1 |
Mehta, P | 1 |
SCHWARTZ, WB | 1 |
RELMAN, AS | 1 |
LEAF, A | 1 |
BRICAUD, H | 2 |
BROUSTET, P | 2 |
SCHWAB, M | 1 |
TAQUINI, AC | 1 |
RONCORONI, AJ | 1 |
ARAMENDIA, P | 1 |
ROS, AM | 1 |
AGNOLETTO, A | 1 |
MORESCHI, N | 1 |
LONGO, P | 1 |
BROMBERG-SZNEK, S | 1 |
RAFALOWICZ, A | 1 |
PECKENSCHNEIDER, LE | 1 |
POKORNY, C | 1 |
AGOTE POVEDA, IP | 1 |
VILLANUEVA EDO, A | 1 |
SEGAL, MS | 1 |
ATTINGER, EO | 1 |
DUVENCI, J | 1 |
PANAYOTOPOULOS, E | 1 |
VALTIS, D | 1 |
METAXAS, P | 1 |
GOULIS, G | 1 |
Weil, JV | 1 |
García-Gascó, P | 1 |
Salame Gamarra, F | 1 |
Tenllado Doblas, P | 1 |
Chazarra Talens, C | 1 |
Rivera, M | 1 |
Chirinos, E | 1 |
Onnen, I | 1 |
Petitjean, O | 2 |
Bienvenu, A | 1 |
Lasne, F | 1 |
Moutereau, S | 1 |
Iizuka, T | 1 |
Sakai, F | 1 |
Ide, T | 1 |
Miyakawa, S | 1 |
Sato, M | 1 |
Yoshii, S | 1 |
Collier, DJ | 1 |
Nickol, AH | 1 |
Milledge, JS | 1 |
van Ruiten, HJ | 1 |
Collier, CJ | 1 |
Swenson, ER | 1 |
Datta, A | 1 |
Wolff, CB | 1 |
Luntz, MH | 1 |
Privat, C | 1 |
Pham, I | 1 |
Macarlupu, JL | 1 |
Skatrud, JB | 1 |
Berssenbrugge, AD | 1 |
Rames, I | 1 |
Kristufek, V | 1 |
Kerty, E | 2 |
Eide, N | 1 |
Hørven, I | 2 |
Kuwabara, Y | 3 |
Ichiya, Y | 3 |
Sasaki, M | 3 |
Yoshida, T | 3 |
Masuda, K | 3 |
Akashi, Y | 2 |
Fukumura, T | 2 |
DeBacker, WA | 1 |
Verbraecken, J | 1 |
Willemen, M | 1 |
Wittesaele, W | 1 |
DeCock, W | 1 |
Van deHeyning, P | 1 |
Fujii, K | 1 |
Fukui, M | 1 |
Farber, MD | 1 |
Lam, S | 1 |
Tessler, HH | 1 |
Jennings, TJ | 1 |
Cross, A | 1 |
Rusin, MM | 1 |
Yamamoto, N | 1 |
Whitcup, SM | 1 |
Csaky, KG | 1 |
Podgor, MJ | 1 |
Chew, EY | 1 |
Perry, CH | 1 |
Nussenblatt, RB | 1 |
Hacein-Bey, L | 1 |
Nour, R | 1 |
Pile-Spellman, J | 1 |
Van Heertum, R | 1 |
Esser, PD | 1 |
Young, WL | 1 |
Kazumata, K | 1 |
Tanaka, N | 1 |
Ishikawa, T | 1 |
Kuroda, S | 3 |
Houkin, K | 1 |
Mitsumori, K | 3 |
Huff, AL | 1 |
Hupp, SL | 1 |
Rothrock, JF | 1 |
Flach, A | 1 |
Rho, D | 1 |
Gambhir, S | 1 |
Inao, S | 1 |
Tadokoro, M | 1 |
Nishino, M | 1 |
Ito, K | 1 |
Ishigaki, T | 1 |
Kuchiwaki, H | 1 |
Yoshida, J | 1 |
Grover, S | 1 |
Fishman, GA | 1 |
Fiscella, RG | 1 |
Adelman, AE | 1 |
Ficzere, A | 1 |
Valikovics, A | 1 |
Fülesdi, B | 1 |
Juhász, A | 1 |
Czuriga, I | 1 |
Csiba, L | 1 |
Ohnishi, T | 1 |
Yano, T | 1 |
Nakano, S | 1 |
Jinnouchi, S | 1 |
Nagamachi, S | 1 |
Flores, LI | 1 |
Nakahara, H | 1 |
Watanabe, K | 1 |
Manni, GL | 1 |
Centofanti, M | 1 |
Napoli, D | 1 |
Parisi, V | 1 |
Bucci, MG | 1 |
Nariai, T | 1 |
Senda, M | 1 |
Ishii, K | 1 |
Wakabayashi, S | 1 |
Yokota, T | 1 |
Toyama, H | 1 |
Matsushima, Y | 1 |
Hirakawa, K | 1 |
Ulrich, PT | 1 |
Kroppenstedt, S | 1 |
Heimann, A | 1 |
Kempski, O | 1 |
Tanaka, A | 1 |
Yoshinaga, S | 1 |
Nakayama, Y | 1 |
Tomonaga, M | 1 |
Flach, AJ | 1 |
Lorberboym, M | 1 |
Lampl, Y | 1 |
Kesler, A | 1 |
Sadeh, M | 1 |
Gadot, N | 1 |
Chang, CC | 1 |
Kanno, H | 1 |
Yamamoto, I | 1 |
Kuwana, N | 1 |
van de Ven, MJ | 1 |
Colier, WN | 1 |
van der Sluijs, MC | 1 |
Oeseburg, B | 1 |
Vis, P | 1 |
Folgering, H | 1 |
Murakami, M | 1 |
Yonehara, T | 1 |
Takaki, A | 1 |
Fujioka, S | 1 |
Hirano, T | 1 |
Ushio, Y | 1 |
Bear, R | 1 |
Goldstein, M | 1 |
Phillipson, E | 1 |
Ho, M | 1 |
Hammeke, M | 1 |
Feldman, R | 1 |
Handelsman, S | 1 |
Halperin, M | 1 |
Demailly, P | 2 |
Duperre, J | 1 |
Wilensky, MC | 1 |
Bondoli, A | 1 |
De Cosmo, G | 1 |
Dordoni, L | 1 |
Magalini, SI | 1 |
Miller, PD | 1 |
Berns, AS | 1 |
Epstein, DL | 1 |
Grant, WM | 1 |
Coe, FL | 1 |
Firpo, JJ | 1 |
Hollandsworth, DL | 1 |
Segil, L | 1 |
Canterbury, JM | 1 |
Reiss, E | 1 |
Clivati, A | 1 |
Ciofetti, M | 1 |
Cavestri, R | 1 |
Longhini, E | 1 |
Sacks, W | 3 |
Esser, AH | 3 |
Sacks, S | 1 |
Gelişken, O | 1 |
Gelişken, F | 1 |
Ozçetin, H | 1 |
Takigawa, S | 2 |
Kamiyama, H | 2 |
Abe, H | 2 |
Sakuragi, M | 2 |
Motomiya, M | 2 |
Nakagawa, T | 2 |
Tsuru, M | 2 |
Senn, P | 1 |
Kopp, B | 1 |
Feitel, B | 1 |
Abbott, K | 1 |
Kaiser, S | 1 |
Gerok, W | 1 |
Häussinger, D | 1 |
Cowen, MA | 1 |
Green, MR | 1 |
Talarico, P | 1 |
Cankosyan, G | 1 |
Cox, SN | 1 |
Hay, E | 1 |
Bird, AC | 1 |
Berke, SJ | 1 |
Bellows, AR | 1 |
Shingleton, BJ | 1 |
Richter, CU | 1 |
Hutchinson, BT | 1 |
Gougoux, A | 1 |
Vinay, P | 1 |
Zizian, L | 1 |
Tejedor, A | 1 |
Noel, J | 1 |
Patsch, J | 1 |
Raptis, S | 1 |
Dollinger, H | 1 |
Rothenbuchner, G | 1 |
Fussgänger, R | 1 |
Klör, U | 1 |
Pfeiffer, EF | 1 |
Dancheva, LD | 1 |
Schüren, KP | 1 |
Hüttemann, U | 1 |
Halpern, SE | 1 |
Tubis, M | 1 |
Golden, M | 1 |
Kunsa, J | 1 |
Endow, J | 1 |
Walsh, C | 1 |
Strachan, I | 1 |
Evans, PJ | 1 |
Dotti, A | 1 |
Mombelloni, P | 1 |
Fassio, PG | 1 |
Beck, GJ | 1 |
Grenard, S | 1 |
Weekers, R | 1 |
Avasthi, P | 1 |
Sharma, SD | 1 |
Luthra, MC | 1 |
Martin, B | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Treatment of High-altitude Sleep Disturbance: A Double-blind Comparison of Temazepam Versus Acetazolamide.[NCT01519544] | 34 participants (Actual) | Interventional | 2012-03-31 | Completed | |||
Double-blind Randomized Acetazolamide Trial in Normal Pressure Hydrocephalus[NCT04975269] | Phase 2 | 50 participants (Anticipated) | Interventional | 2022-02-17 | Recruiting | ||
Hypoventilation and High Altitude Chronic Polycythemia: Acetazolamide as a Possible Treatment[NCT00424970] | Phase 4 | 55 participants (Anticipated) | Interventional | 2007-01-31 | Completed | ||
Randomized Controlled Trial of N-acetylcysteine and Acetazolamide in Treatment of Chronic Mountain Sickness[NCT01187108] | Phase 1/Phase 2 | 85 participants (Actual) | Interventional | 2013-06-30 | Completed | ||
[NCT00000115] | Phase 2 | 0 participants | Interventional | 1990-12-31 | Completed | ||
C-arm Cone Beam CTA and CTP With Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage: Evaluating Predictability for Early Ischemia in Cerebral Vasospasm[NCT03377049] | Phase 4 | 11 participants (Actual) | Interventional | 2019-07-28 | Completed | ||
The Effect of Topical Corticosteroids and Topical NSAIDs Perioperatively on IL6 Levels in Aqueous Humor and on Incidence of PCME in Patients With NPDR[NCT04940338] | Phase 4 | 90 participants (Actual) | Interventional | 2021-05-01 | Completed | ||
Changes of Macular Vasculature After Uncomplicated Phacoemulsification Surgery Using Optical Coherence Tomography Angiography[NCT04594603] | 30 participants (Anticipated) | Observational [Patient Registry] | 2021-04-13 | Recruiting | |||
Brain During Effort : Effects of Hypoxia With Respiratory Patients[NCT02854280] | 33 participants (Actual) | Interventional | 2013-06-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Clinical neurological deterioration not attributable to other causes, mores specifically not due to re-bleeding, hydrocephalus, or metabolic changes. (NCT03377049)
Timeframe: Day 1-14 during the hospitalization
Intervention | Participants (Count of Participants) |
---|---|
Acetazolamide Challenge | 2 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
Intervention | percent change (Mean) |
---|---|
Acetazolamide Challenge | 19.785 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
Intervention | percent change (Mean) |
---|---|
Acetazolamide Challenge | 21.659 |
The data that will be statistically compared is the pre-diamox perfusion in comparison to the post-diamox perfusion. A statistically significant change increase in CBF represents an appropriate response to Diamox. Lack of change in CBF or decrease in CBF could be suggestive of potential for developing vasospasm. (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
Intervention | percent change (Mean) |
---|---|
Acetazolamide Challenge | 20.722 |
9 reviews available for acetazolamide and Chronic Disease
Article | Year |
---|---|
[The preventive effect of four drugs on acute mountain sickness: a Bayesian network meta-analysis].
Topics: Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Chronic Disease; Humans; Network Meta-Ana | 2021 |
Medical Conditions and High-Altitude Travel.
Topics: Acetazolamide; Altitude; Altitude Sickness; Brain Edema; Chronic Disease; Dexamethasone; Female; Hum | 2022 |
Murine typhus as a cause of cognitive impairment: case report and a review of the literature.
Topics: Acetazolamide; Adolescent; Anticonvulsants; Brain; Chronic Disease; Cognition Disorders; Diagnosis, | 2014 |
Sleep at high altitude.
Topics: Acetazolamide; Altitude Sickness; Benzodiazepines; Carbonic Anhydrase Inhibitors; Chronic Disease; H | 2004 |
Treatment of chronic mountain sickness: critical reappraisal of an old problem.
Topics: Acclimatization; Acetazolamide; Altitude; Altitude Sickness; Angiotensin-Converting Enzyme Inhibitor | 2007 |
Effect of sleep state and chemical stimuli on breathing.
Topics: Acetazolamide; Bicarbonates; Carbon Dioxide; Chronic Disease; Humans; Lung Diseases, Obstructive; Me | 1983 |
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; | 1998 |
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; | 1998 |
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; | 1998 |
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; | 1998 |
[A review of glaucoma 1974-1975].
Topics: Acetazolamide; Chronic Disease; Diagnosis, Differential; Female; Glaucoma; Guanethidine; Humans; Hyd | 1976 |
[Glaucoma].
Topics: Acetazolamide; Angiography; Aqueous Humor; Cataract; Cholinesterase Inhibitors; Chronic Disease; Dex | 1968 |
20 trials available for acetazolamide and Chronic Disease
Article | Year |
---|---|
Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.
Topics: Acetazolamide; Administration, Intravenous; Aged; Aged, 80 and over; Chronic Disease; Diuretics; Dos | 2017 |
Near-infrared transillumination back scattering sounding--new method to assess brain microcirculation in patients with chronic carotid artery stenosis.
Topics: Acetazolamide; Aged; Aged, 80 and over; Blood Volume; Carotid Stenosis; Cerebrovascular Circulation; | 2013 |
Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness.
Topics: Acetazolamide; Adult; Altitude Sickness; Analysis of Variance; Anticonvulsants; Carbon Dioxide; Chro | 2008 |
Acetazolamide: a treatment for chronic mountain sickness.
Topics: Acetazolamide; Administration, Oral; Adult; Altitude Sickness; Blood Pressure; Carbonic Anhydrase In | 2005 |
Alveolar PCO2 oscillations and ventilation at sea level and at high altitude.
Topics: Acclimatization; Acetazolamide; Acute Disease; Administration, Inhalation; Altitude; Bicycling; Carb | 2008 |
GLAUCOMA TREATED WITH DARANIDE A CLINICAL TRIAL.
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Chronic Disease; Dichlorphenamide; Drug Therapy, | 1961 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
[Effect of different saluretics on carbohydrate metabolism and blood pressure behavior in diabetics].
Topics: Acetazolamide; Aged; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Chronic Disease; Clinic | 1984 |
[A comparison of the cerebrovascular responses to CO2 and Diamox in patients with unilateral occlusive cerebral arteries: a H2(15)O PET study].
Topics: Acetazolamide; Aged; Carbon Dioxide; Cerebrovascular Circulation; Chronic Disease; Female; Humans; I | 1995 |
Central apnea index decreases after prolonged treatment with acetazolamide.
Topics: Acetazolamide; Analysis of Variance; Chronic Disease; Female; Humans; Male; Middle Aged; Polysomnogr | 1995 |
[Pre and post operative evaluation of the perfusion reserve by acetazolamide 99mTc-HMPAO SPECT in patients with chronic occlusive cerebral arteries: a comparative study with PET].
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Cerebral Revasc | 1994 |
Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study.
Topics: Acetazolamide; Adult; Age Factors; Aged; Chronic Disease; Delayed-Action Preparations; Double-Blind | 1994 |
[Usefulness of change ratio map in 99mTc-HMPAO SPECT with acetazolamide enhancement].
Topics: Acetazolamide; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; | 1996 |
A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis.
Topics: Acetazolamide; Adolescent; Adult; Aged; Carbonic Anhydrase Inhibitors; Chronic Disease; Cross-Over S | 1996 |
Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Carbonic Anhy | 1997 |
Cerebrovascular reactivity in hypertensive patients: a transcranial Doppler study.
Topics: Acetazolamide; Adult; Aorta; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circulation; Ch | 1997 |
Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Chronic | 1997 |
Cerebrovascular reactivity to acetazolamide in alert patients with cerebral infarction: usefulness of first-pass radionuclide angiography using 99m Tc-HMPAO in monitoring cerebral haemodynamics.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Cere | 2001 |
Acetazolamide and thiamine: an ancillary therapy for chronic mental illness.
Topics: Acetazolamide; Adult; Blood Glucose; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; | 1989 |
Acetazolamide and thiamine (A+T): a preliminary report of an ancillary therapy for chronic mental illness.
Topics: Acetazolamide; Adult; Age Factors; Aged; Aged, 80 and over; Chronic Disease; Clinical Trials as Topi | 1988 |
67 other studies available for acetazolamide and Chronic Disease
Article | Year |
---|---|
Regional resting state perfusion variability and delayed cerebrovascular uniform reactivity in subjects with chronic carotid artery stenosis.
Topics: Acetazolamide; Aged; Brain Stem; Carotid Stenosis; Cerebrovascular Circulation; Chronic Disease; Fem | 2018 |
Acetazolamide can cause acute hypercrystalluria.
Topics: Acetazolamide; Altitude Sickness; Chronic Disease; Humans; Mountaineering | 2018 |
Chronic Meningitis Complicating Intracranial Hypertension in Neurobrucellosis: A Case Report.
Topics: Acetazolamide; Adult; Anti-Bacterial Agents; Blood Glucose; Brucella; Brucellosis; Central Nervous S | 2015 |
Recurrent epistaxis following stabbing headache responsive to acetazolamide.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Chronic Disease; Epistaxis; Female; Headache Disorders | 2014 |
Aquaporin 4 inhibition decreased synthesis of cytokines by acetazolamide in the hippocampus of rats with pentrazol-induced chronic epilepsy.
Topics: Acetazolamide; Animals; Aquaporin 4; Chronic Disease; Cytokines; Epilepsy; Hippocampus; Kindling, Ne | 2016 |
Effect of perindopril on vasoreactivity in patients with hypertensive chronic cerebrovascular disease. A comparative analysis of different brain structures.
Topics: Acetazolamide; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascu | 2008 |
Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.
Topics: Acetazolamide; Aldosterone; Animals; Calcium; Chronic Disease; Disease Models, Animal; Homeostasis; | 2008 |
Aquaporin-1 expression and angiogenesis in rabbit chronic myocardial ischemia is decreased by acetazolamide.
Topics: Acetazolamide; Animals; Aquaporin 1; Capillaries; Carbonic Anhydrase Inhibitors; Chronic Disease; Di | 2010 |
Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics.
Topics: Acetazolamide; Altitude Sickness; Animals; Blood Viscosity; Blood Volume; Carbonic Anhydrase Inhibit | 2012 |
A case report of orbital haemorrhage associated with endoscopic sinus surgery and reversible sight loss: a multidisciplinary approach to management.
Topics: Acetazolamide; Blindness; Chronic Disease; Combined Modality Therapy; Decompression, Surgical; Dexam | 2013 |
Oral administration of a potent carbonic anhydrase inhibitor (diamox). III. Its use as a diuretic in patients with severe congestive heart failure due to cor pulmonale.
Topics: Acetazolamide; Administration, Oral; Carbonic Anhydrase Inhibitors; Chronic Disease; Diuretics; Hear | 1955 |
[Acetazolamide in the treatment of chronic pulmonary heart disease].
Topics: Acetazolamide; Chronic Disease; Humans; Hypertension, Pulmonary; Pulmonary Heart Disease | 1956 |
[Acetazolamide in the treatment of chronic pulmonary heart disease].
Topics: Acetazolamide; Chronic Disease; Humans; Hypertension, Pulmonary; Pulmonary Heart Disease | 1956 |
[Acetazolamide in the treatment of chronic pulmonary heart disease].
Topics: Acetazolamide; Chronic Disease; Humans; Hypertension, Pulmonary; Pulmonary Heart Disease | 1956 |
[Acetazolamide in the treatment of chronic pulmonary heart disease].
Topics: Acetazolamide; Chronic Disease; Humans; Hypertension, Pulmonary; Pulmonary Heart Disease | 1956 |
[Therapy of pulmonary empyema connected with chronic respiratory acidosis].
Topics: Acetazolamide; Acidosis; Acidosis, Respiratory; Aminophylline; Chronic Disease; Empyema; Empyema, Pl | 1957 |
Sensitivity of respiratory center to carbon dioxide in emphysema and cor pulmonale: effects of carbonic anhydrase inhibition.
Topics: Acetazolamide; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chronic Disease; | 1957 |
[Acetazolamide (diamox) in the treatment of silicosis with severe chronic respiratory insufficiency].
Topics: Acetazolamide; Chronic Disease; Respiratory Insufficiency; Silicosis | 1957 |
[Acetazolamide in therapy of chronic cor pulmonale].
Topics: Acetazolamide; Chronic Disease; Humans; Pulmonary Heart Disease | 1958 |
[Effects of diamox in cor pulmonale].
Topics: Acetazolamide; Chronic Disease; Humans; Hypertension, Pulmonary; Pulmonary Heart Disease | 1958 |
Oral diuril; its use in therapy of chronic heart failure.
Topics: Acetazolamide; Chlorothiazide; Chronic Disease; Heart Failure | 1958 |
[Acetazolamide in the treatment of chronic cor pulmonale].
Topics: Acetazolamide; Chronic Disease; Humans; Hypertension, Pulmonary; Pulmonary Heart Disease | 1958 |
Chronic cor pulmonale; its management; notes on the use of chlorothiazide (diuril).
Topics: Acetazolamide; Chlorothiazide; Chronic Disease; Disease Management; Humans; Pulmonary Heart Disease | 1959 |
[The influence of acetazolamide on patients with chronic respiratory insufficiency].
Topics: Acetazolamide; Chronic Disease; Leadership; Pulmonary Emphysema; Respiratory Insufficiency | 1960 |
[Complete resolution of chronic hydrocephalus of adult with acetazolamide].
Topics: Acetazolamide; Aged; Brain; Carbonic Anhydrase Inhibitors; Chronic Disease; Cognition Disorders; Fem | 2005 |
Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS -- implication of neurovascular cellular mechanism.
Topics: Acetazolamide; Adult; Aged; Brain; Carbonic Anhydrases; Cerebral Arteries; Cerebrovascular Circulati | 2007 |
Ocular hemodynamic changes in patients with high-grade carotid occlusive disease and development of chronic ocular ischaemia. II. Clinical findings.
Topics: Acetazolamide; Aged; Aged, 80 and over; Blindness; Blood Flow Velocity; Carotid Artery, Internal; Ca | 1995 |
Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Pressure; Brain Ischemia; Carotid Artery, In | 1995 |
Ocular hemodynamic changes in patients with high-grade carotid occlusive disease and development of chronic ocular ischaemia. I. Doppler and dynamic tonometry findings.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Carotid Artery, Internal; Caroti | 1995 |
Adaptive changes of autoregulation in chronic cerebral hypotension with arteriovenous malformations: an acetazolamide-enhanced single-photon emission CT study.
Topics: Acetazolamide; Adaptation, Physiological; Adolescent; Adult; Blood Pressure; Carbonic Anhydrase Inhi | 1995 |
Dissociation of vasoreactivity to acetazolamide and hypercapnia. Comparative study in patients with chronic occlusive major cerebral artery disease.
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Cerebral Infarction; Cerebrovascular Circulation | 1996 |
Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Chronic Disease; Female; Headache; Humans; Intracranial Pressure; Middle Aged; | 1996 |
Acetazolamide treatment of CME in patients with uveitis.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Chronic Disease; Humans; Macular Edema; Randomized Con | 1996 |
Acetazolamide treatment of CME in patients with uveitis.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Chronic Disease; Humans; Macular Edema; Randomized Con | 1996 |
Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography.
Topics: Acetazolamide; Administration, Inhalation; Aged; Carbon Dioxide; Cerebrovascular Circulation; Cerebr | 1997 |
Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
Topics: Acetazolamide; Aged; Aged, 80 and over; Amphetamines; Cerebrovascular Circulation; Cerebrovascular D | 1997 |
Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study.
Topics: Acetazolamide; Administration, Inhalation; Adult; Aged; Blood Volume; Brain; Brain Ischemia; Carbon | 1998 |
Laser-Doppler scanning of local cerebral blood flow and reserve capacity and testing of motor and memory functions in a chronic 2-vessel occlusion model in rats.
Topics: Acetazolamide; Animals; Anticonvulsants; Arterial Occlusive Diseases; Behavior, Animal; Blood Pressu | 1998 |
Cerebral blood flow and the response to acetazolamide during the acute, subacute, and chronic stages of aneurysmal subarachnoid hemorrhage.
Topics: Acetazolamide; Acute Disease; Adult; Aged; Aged, 80 and over; Cerebrovascular Circulation; Chronic D | 1998 |
Benign intracranial hypertension: correlation of cerebral blood flow with disease severity.
Topics: Acetazolamide; Adult; Brain; Cerebrovascular Circulation; Chronic Disease; Diuretics; Female; Humans | 2001 |
Effects of acetazolamide and furosemide on ventilation and cerebral blood volume in normocapnic and hypercapnic patients with COPD.
Topics: Acetazolamide; Administration, Oral; Alkalosis; Blood Volume; Carbon Dioxide; Cerebrovascular Circul | 2002 |
Evaluation of delayed appearance of acetazolamide effect in patients with chronic cerebrovascular ischemic disease: feasibility and usefulness of SPECT method using triple injection of ECD.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Brain Ischemia; Carotid Artery, Internal; Carotid Ste | 2002 |
Effect of metabolic alkalosis on respiratory function in patients with chronic obstructive lung disease.
Topics: Acetazolamide; Acidosis, Respiratory; Aged; Alkalosis; Ammonium Chloride; Bicarbonates; Blood Gas An | 1977 |
Curent concepts in primary angle-closure glaucoma.
Topics: Acetazolamide; Acute Disease; Chronic Disease; Glaucoma; Glycerol; Humans; Mannitol; Moxisylyte | 1977 |
[Acetazolamide in respiratory insufficiency].
Topics: Acetazolamide; Acid-Base Imbalance; Acute Disease; Brain Injuries; Chronic Disease; Humans; Hypercap | 1979 |
Acute metabolic alkalosis perpetuating hypercarbia. A role for acetazolamide in chronic obstructive pulmonary disease.
Topics: Acetazolamide; Aged; Alkalosis; Bicarbonates; Carbon Dioxide; Chronic Disease; Diuretics; Female; He | 1977 |
Carbonic anhydrase inhibitor side effects. Serum chemical analysis.
Topics: Acetazolamide; Bicarbonates; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Chronic Disease; Glaucom | 1977 |
Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man.
Topics: Acetazolamide; Acidosis; Acute Disease; Ammonium Chloride; Calcium; Chronic Disease; Female; Glomeru | 1975 |
Cerebral vascular responsiveness in chronic hypercapnia.
Topics: Acetazolamide; Aged; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circulation; Chronic Di | 1992 |
Inhibition of pyruvate dehydrogenase complex (PDHC) by antipsychotic drugs.
Topics: Acetazolamide; Ambulatory Care; Animals; Brain; Cattle; Chronic Disease; Drug Therapy, Combination; | 1991 |
Treatment of chronic macular oedema with low dosage acetazolamide.
Topics: Acetazolamide; Aged; Chronic Disease; Female; Humans; Macular Edema; Male; Middle Aged | 1990 |
[Diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; the detection of impaired vasodilatory capacity with 133Xe SPECT and acetazolamide (Diamox) test].
Topics: Acetazolamide; Adult; Aged; Blood Pressure; Brain Ischemia; Cerebral Revascularization; Cerebrovascu | 1990 |
[Nd:YAG laser synechiolysis in glaucoma due to iridocorneal angle synechiae].
Topics: Acetazolamide; Aged; Aged, 80 and over; Chronic Disease; Combined Modality Therapy; Female; Follow-U | 1990 |
[Diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; measurement of cerebral blood volume (CBV) with 99mTc-RBC SPECT].
Topics: Acetazolamide; Adult; Aged; Blood Volume; Brain Ischemia; Cerebrovascular Circulation; Chronic Disea | 1990 |
Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonaemia in chronic liver disease.
Topics: Acetazolamide; Ammonia; Bicarbonates; Chronic Disease; Glutamine; Humans; Liver; Liver Diseases; Ure | 1988 |
Treatment of chronic macular edema with acetazolamide.
Topics: Acetazolamide; Chronic Disease; Dose-Response Relationship, Drug; Eye Diseases; Fluorescein Angiogra | 1988 |
Chronic and recurrent choroidal detachment after glaucoma filtering surgery.
Topics: Acetazolamide; Aged; Aged, 80 and over; Choroid; Chronic Disease; Female; Glaucoma, Open-Angle; Huma | 1987 |
Effect of acetazolamide on renal metabolism and ammoniagenesis in the dog.
Topics: Acetazolamide; Acidosis; Ammonium Chloride; Animals; Chronic Disease; Citrates; Citric Acid; Dogs; G | 1987 |
[Blood oxygen pressure as a criterion of pulmonary function and therapy].
Topics: Acetazolamide; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Anti-Bacterial Agents; A | 1971 |
Effect of acetazolamide on the insulin response to intravenous administration of secretin.
Topics: Acetazolamide; Antigens; Bicarbonates; Blood Glucose; Chronic Disease; Drug Synergism; Duodenum; Fat | 1974 |
[A new approach in determining the indications for surgical intervention in glaucoma].
Topics: Acetazolamide; Adult; Aged; Chronic Disease; Glaucoma; Humans; Intraocular Pressure; Methods; Middle | 1972 |
[Cardiac therapy of chronic bronchitis (author's transl)].
Topics: Acetazolamide; Bloodletting; Bronchitis; Chronic Disease; Digitalis Glycosides; Diuretics; Hemodynam | 1974 |
99m TPAC, a new renal scanning agent. II. Evaluation in humans.
Topics: Acetazolamide; Adenocarcinoma; Adolescent; Adult; Arteriosclerosis; Child; Chronic Disease; Diabetic | 1972 |
A method of determining the site of outflow resistance.
Topics: Acetazolamide; Aqueous Humor; Chronic Disease; Ciliary Body; Cornea | 1970 |
Modern problems in glaucoma.
Topics: Acetazolamide; Acute Disease; Aged; Bicarbonates; Chronic Disease; Ciliary Body; Dichlorphenamide; E | 1971 |
[Evaluation of the effects of various diuretics in chronic lung diseases with chronic respiratory insufficiency (CRI)].
Topics: Acetazolamide; Amides; Chronic Disease; Clopamide; Diuretics; Humans; Hydrogen-Ion Concentration; Lu | 1969 |
Intensive respiratory care: advances in management of patients with obstructive pulmonary disease.
Topics: Acetazolamide; Blood; Blood Gas Analysis; Carbon Dioxide; Chronic Disease; Humans; Hydrogen-Ion Conc | 1970 |
[Treatment of open angle glaucoma (synonym: chronic simple glaucoma)].
Topics: Acetazolamide; Acetylcholine; Carbonic Anhydrase Inhibitors; Chronic Disease; Dichlorphenamide; Echo | 1968 |
Influence of drugs on aqueous flow in chronic simple glaucoma.
Topics: Acetazolamide; Adult; Aqueous Humor; Chronic Disease; Female; Glaucoma; Glycerol; Humans; Intraocula | 1968 |
Infiltration of the iris in chronic lymphatic leukaemia.
Topics: Acetazolamide; Chlorambucil; Chronic Disease; Glaucoma; Humans; Intraocular Pressure; Iris; Leukemia | 1968 |